The article focuses on the study conducted in Ann Arbor, Michigan regarding the developments in treating chronic myeloid leukemia (CML). The authors discuss the molecular discoveries and clinical advances which are made to improve the treatment of CML. Moreover , they talk about the variety of approaches in treating CML as well as the efforts to minimize treatment failure.